Pharmacy

The largest public-private partnership in the biopharmaceutical sector, Innovative Medicines Initiative (IMI) launched its second wave of research projects, which includes cancer, immune-mediated diseases, infectious disorders and electronic health. With 23 projects up and the European Federation of Pharmaceutical Industries and Associations (EFPIA) on a uniquely large scale. IMI would now be sharing their current as well as future R&D with Europe. Maire   Geoghegan-Quinn,   Commissioner for Research, Innovation and Science, said, "By speeding up drug development across Europe, investments made by the IMI will ultimately save and improve lives, as well as make a major contribution to the Innovation Union and to' growth and jobs."